Natural Product: NPC489610

Natural Product IDNPC489610
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
AQTQHPDCURKLKT-JKDPCDLQSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 249332
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000279] Alkaloids and derivatives
      • [CHEMONTID:0002756] Vinca alkaloids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey AQTQHPDCURKLKT-JKDPCDLQSA-N
Standard InCHI InChI=1S/C46H56N4O10.H2O4S/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6;1-5(2,3)4/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3;(H2,1,2,3,4)/t28-,37+,38-,39-,42+,43-,44-,45+,46+;/m1./s1
SMILES CC[C@@]1(C[C@@H]2C[C@](c3cc4c(cc3OC)N(C=O)[C@@H]3[C@@]54CCN4CC=C[C@](CC)([C@@H]54)[C@H]([C@@]3(C(=O)OC)O)OC(=O)C)(c3c(CCN(C2)C1)c1ccccc1[nH]3)C(=O)OC)O.OS(=O)(=O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   824.4 Volume:   827.415
?
Van der Waals volume.
Dense:   0.996 LogP:   2.88
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.722
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.301
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   11.0 Rigid Bonds:   49.0
TPSA:   171.17
?
Topological Polar Surface Area.
H-Bond Acceptor:   14.0
H-Bond Donor:   3.0 Rings:   9.0
Heavy Atoms:   14.0

MedChem Properties

QED Drug-Likeness Score:   0.131 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   7.261 Fsp3:   0.565
MCE-18:   270.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.364 Fluc inhibitor:   0.005
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.699
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.868
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.001 Promiscuous compounds:   0.994

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.168 MDCK Permeability:   -5.21
Pgp-inhibitor:   0.0 Pgp-substrate:   1.0
PAMPA:   0.237
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.184 30% Bioavailability (F30%):   0.939
50% Bioavailability (F50%):   0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.697 MRP1:   1.0
Plasma Protein Binding (PPB):   64.325% Volume Distribution (VD):   0.38
Fu: 33.31%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.465
OATP1B3 inhibitor:   0.228 BCRP inhibitor:   0.791
BSEP inhibitor:   0.997

ADMET: Metabolism

CYP1A2-inhibitor:   0.999 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   1.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.028
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   1.0
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   0.888
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.858
HLM stability:   0.919
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  3.294 Half-life (T1/2):  1.633

ADMET: Toxicity

hERG Blockers:  0.556 hERG Blockers (10um):  0.153
Human Hepatotoxicity (H-HT):  0.918 Drug-induced Liver Injury (DILI):  0.722
AMES Toxicity:  0.577 Rat Oral Acute Toxicity:  0.864
Maximum Recommended Daily Dose:  1.0 Skin Sensitization:  1.0
Carcinogencity:  0.225 Eye Corrosion:  0.0
Eye Irritation:  0.0 Respiratory Toxicity:  0.997
Drug-induced Neurotoxicity:  0.904 Ototoxicity:  0.901
Hematotoxicity:  0.716 Drug-induced Nephrotoxicity:  1.0
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.623
A549 Cytotoxicity:  0.99 Hek293 Cytotoxicity:  0.945
BCF:   0.581
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.861
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.641
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.889
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO40305 Pseudoceratina verrucosa Species Pseudoceratinidae Eukaryota n.a. n.a. n.a. PMID[23489291]
NPO40305 Pseudoceratina verrucosa Species Pseudoceratinidae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1249 Individual protein Canalicular multispecific organic anion transporter 2 Homo sapiens IC50 > 133000.0 nM PMID[23956101]
NPT1028 Individual protein Multidrug resistance-associated protein 4 Homo sapiens IC50 > 133000.0 nM PMID[23956101]
NPT713 Individual protein Bile salt export pump Homo sapiens IC50 > 133000.0 nM PMID[23956101]
NPT67 Individual protein Cholinesterase Equus caballus Inhibition = 2.81 % PMID[23062825]
NPT612 Individual protein Canalicular multispecific organic anion transporter 1 Homo sapiens IC50 > 133000.0 nM PMID[23956101]
NPT66 Individual protein Acetylcholinesterase Electrophorus electricus Inhibition = 10.9 % PMID[23062825]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2589 Cell line Panel leukemia (Carcinoma cell lines) Homo sapiens GI50 = 100.0 nM PMID[12036377]
NPT3877 Cell line NSCLC Homo sapiens GI50 = 251.19 nM PMID[12036377]
NPT2589 Cell line Panel leukemia (Carcinoma cell lines) Homo sapiens TGI = -4.8 n.a. PMID[12036377]
NPT3877 Cell line NSCLC Homo sapiens TGI = -4.8 n.a. PMID[12036377]
NPT4720 Cell line Leukemia cells Homo sapiens GI50 = 7.0 n.a. PMID[16107161]
NPT517 Cell line Panel NCI-60 (60 carcinoma cell lines) Homo sapiens GI50 = 6.7 n.a. PMID[16107161]
NPT4720 Cell line Leukemia cells Homo sapiens TGI = 4.8 n.a. PMID[16107161]
NPT3877 Cell line NSCLC Homo sapiens TGI = 4.8 n.a. PMID[16107161]
NPT6511 Cell line Colon cells Homo sapiens TGI = 5.4 n.a. PMID[16107161]
NPT5530 Cell line CNS cells Homo sapiens TGI = 5.2 n.a. PMID[16107161]
NPT3880 Cell line Melanoma cells Homo sapiens TGI = 5.1 n.a. PMID[16107161]
NPT6428 Cell line Ovarian carcinoma cells Homo sapiens TGI = 4.7 n.a. PMID[16107161]
NPT6593 Cell line Renal cells Homo sapiens TGI = 4.7 n.a. PMID[16107161]
NPT6369 Cell line Prostate cells Homo sapiens TGI = 5.2 n.a. PMID[16107161]
NPT5230 Cell line Breast carcinoma cells Homo sapiens TGI = 5.1 n.a. PMID[16107161]
NPT3877 Cell line NSCLC Homo sapiens GI50 = 6.6 n.a. PMID[16107161]
NPT517 Cell line Panel NCI-60 (60 carcinoma cell lines) Homo sapiens TGI = 5.0 n.a. PMID[16107161]
NPT6511 Cell line Colon cells Homo sapiens GI50 = 7.0 n.a. PMID[16107161]
NPT5530 Cell line CNS cells Homo sapiens GI50 = 6.9 n.a. PMID[16107161]
NPT3880 Cell line Melanoma cells Homo sapiens GI50 = 6.8 n.a. PMID[16107161]
NPT6428 Cell line Ovarian carcinoma cells Homo sapiens GI50 = 6.5 n.a. PMID[16107161]
NPT6593 Cell line Renal cells Homo sapiens GI50 = 6.5 n.a. PMID[16107161]
NPT6369 Cell line Prostate cells Homo sapiens GI50 = 6.9 n.a. PMID[16107161]
NPT5230 Cell line Breast carcinoma cells Homo sapiens GI50 = 6.5 n.a. PMID[16107161]
NPT377 Cell line OVCAR-3 Homo sapiens IC50 = 10.0 nM PMID[15857148]
NPT458 Cell line IGROV-1 Homo sapiens IC50 = 10.0 nM PMID[15857148]
NPT83 Cell line MCF7 Homo sapiens IC50 = 10.0 nM PMID[15857148]
NPT2318 Cell line A172 Homo sapiens IC50 > 100000.0 nM PMID[15857148]
NPT139 Cell line HT-29 Homo sapiens IC50 = 100.0 nM PMID[15857148]
NPT65 Cell line HepG2 Homo sapiens IC50 = 100.0 nM PMID[15857148]
NPT2589 Cell line Panel leukemia (Carcinoma cell lines) Homo sapiens GI50 = 100.0 nM PMID[17154522]
NPT2589 Cell line Panel leukemia (Carcinoma cell lines) Homo sapiens TGI = 15848.93 nM PMID[17154522]
NPT3877 Cell line NSCLC Homo sapiens GI50 = 251.19 nM PMID[17154522]
NPT3877 Cell line NSCLC Homo sapiens TGI = 15848.93 nM PMID[17154522]
NPT116 Cell line HL-60 Homo sapiens IC50 = 11.2 ug.mL-1 PMID[17432904]
NPT3877 Cell line NSCLC Homo sapiens GI50 = 251.19 nM PMID[17559205]
NPT3877 Cell line NSCLC Homo sapiens TGI = 15848.93 nM PMID[17559205]
NPT4720 Cell line Leukemia cells Homo sapiens GI50 = 100.0 nM PMID[19006285]
NPT3877 Cell line NSCLC Homo sapiens GI50 = 251.19 nM PMID[19006285]
NPT3880 Cell line Melanoma cells Homo sapiens GI50 = 158.49 nM PMID[19006285]
NPT4720 Cell line Leukemia cells Homo sapiens TGI = 15848.93 nM PMID[19006285]
NPT3877 Cell line NSCLC Homo sapiens TGI = 15848.93 nM PMID[19006285]
NPT3880 Cell line Melanoma cells Homo sapiens TGI = 7943.28 nM PMID[19006285]
NPT4720 Cell line Leukemia cells Homo sapiens GI = 0.1 uM PMID[19006285]
NPT3877 Cell line NSCLC Homo sapiens GI = 0.25 uM PMID[19006285]
NPT3880 Cell line Melanoma cells Homo sapiens GI = 0.16 uM PMID[19006285]
NPT3877 Cell line NSCLC Homo sapiens GI50 = 200.0 nM PMID[20395150]
NPT3877 Cell line NSCLC Homo sapiens TGI = 15800.0 nM PMID[20395150]
NPT3877 Cell line NSCLC Homo sapiens GI50 = 250.0 nM PMID[20684599]
NPT3877 Cell line NSCLC Homo sapiens TGI = 15850.0 nM PMID[20684599]
NPT858 Cell line LNCaP Homo sapiens IC50 = 2.9 nM PMID[20732809]
NPT306 Cell line PC-3 Homo sapiens IC50 = 11.0 nM PMID[20732809]
NPT3877 Cell line NSCLC Homo sapiens GI50 = 250.0 nM PMID[22283430]
NPT3877 Cell line NSCLC Homo sapiens TGI = 15850.0 nM PMID[22283430]
NPT1523 Cell line NFF Homo sapiens IC50 = 17.0 nM PMID[23215348]
NPT306 Cell line PC-3 Homo sapiens IC50 = 15.0 nM PMID[23215348]
NPT858 Cell line LNCaP Homo sapiens IC50 = 6.1 nM PMID[23215348]
NPT165 Cell line HeLa Homo sapiens IC50 = 36.0 nM PMID[23215348]
NPT81 Cell line A549 Homo sapiens IC50 = 20.0 nM PMID[23215348]
NPT1523 Cell line NFF Homo sapiens IC50 = 16.9 nM PMID[23489291]
NPT306 Cell line PC-3 Homo sapiens IC50 = 15.3 nM PMID[23489291]
NPT165 Cell line HeLa Homo sapiens IC50 = 35.8 nM PMID[23489291]
NPT2831 Cell line P388/S Mus musculus Activity = 96.0 % PMID[430477]
NPT2831 Cell line P388/S Mus musculus Activity = 138.0 % PMID[430477]
NPT2831 Cell line P388/S Mus musculus Activity = 83.0 % PMID[430477]
NPT5929 Cell line P388/VCR Mus musculus Activity = 0.0 % PMID[430477]
NPT5929 Cell line P388/VCR Mus musculus Activity = 1.2 % PMID[430477]
NPT5929 Cell line P388/VCR Mus musculus Activity = 0.9 % PMID[430477]
NPT5929 Cell line P388/VCR Mus musculus Activity = 0.6 % PMID[430477]
NPT1161 Cell line CHO Cricetulus griseus Activity = 40.0 % PMID[430477]
NPT1161 Cell line CHO Cricetulus griseus Activity = 10.0 % PMID[430477]
NPT1034 Cell line Lu1 Homo sapiens IC50 = 480.0 nM PMID[26522953]
NPT91 Cell line KB Homo sapiens IC50 = 20.0 nM PMID[26522953]
NPT65 Cell line HepG2 Homo sapiens IC50 = 690.0 nM PMID[26522953]
NPT83 Cell line MCF7 Homo sapiens IC50 = 510.0 nM PMID[26522953]
NPT81 Cell line A549 Homo sapiens IC50 = 171.5 nM PMID[28038323]
NPT82 Cell line MDA-MB-231 Homo sapiens IC50 = 116.6 nM PMID[28038323]
NPT457 Cell line BT-549 Homo sapiens IC50 = 54.72 nM PMID[28038323]
NPT306 Cell line PC-3 Homo sapiens IC50 = 27.6 nM PMID[28038323]
NPT90 Cell line DU-145 Homo sapiens IC50 = 72.3 nM PMID[28038323]
NPT90 Cell line DU-145 Homo sapiens IC50 = 71830.0 nM PMID[29174816]
NPT306 Cell line PC-3 Homo sapiens IC50 = 28110.0 nM PMID[29174816]
NPT25899 Cell line Panel colon (Carcinoma cell lines) Homo sapiens GI50 = 100.0 nM PMID[12036377]
NPT25902 Cell line Panel ovarian (Carcinoma cell lines) Homo sapiens GI50 = 316.23 nM PMID[12036377]
NPT25904 Cell line Panel prostate (Carcinoma cell lines) Homo sapiens GI50 = 125.89 nM PMID[12036377]
NPT25899 Cell line Panel colon (Carcinoma cell lines) Homo sapiens TGI = -5.4 n.a. PMID[12036377]
NPT25902 Cell line Panel ovarian (Carcinoma cell lines) Homo sapiens TGI = -4.7 n.a. PMID[12036377]
NPT25904 Cell line Panel prostate (Carcinoma cell lines) Homo sapiens TGI = -5.2 n.a. PMID[12036377]
NPT25899 Cell line Panel colon (Carcinoma cell lines) Homo sapiens GI50 = 100.0 nM PMID[17154522]
NPT25899 Cell line Panel colon (Carcinoma cell lines) Homo sapiens TGI = 3981.07 nM PMID[17154522]
NPT25902 Cell line Panel ovarian (Carcinoma cell lines) Homo sapiens GI50 = 316.23 nM PMID[17154522]
NPT25902 Cell line Panel ovarian (Carcinoma cell lines) Homo sapiens TGI = 19952.62 nM PMID[17154522]
NPT25904 Cell line Panel prostate (Carcinoma cell lines) Homo sapiens GI50 = 125.89 nM PMID[17154522]
NPT25904 Cell line Panel prostate (Carcinoma cell lines) Homo sapiens TGI = 6309.57 nM PMID[17154522]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 100.0 nM PMID[19734910]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 1000.0 nM PMID[19734910]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 199.53 nM PMID[19734910]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 3162.28 nM PMID[19734910]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 1584.89 nM PMID[19734910]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 50.12 nM PMID[19734910]
NPT25901 Cell line Panel melanoma (Carcinoma cell lines) Homo sapiens GI50 = 158.49 nM PMID[12036377]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 199.53 nM PMID[12036377]
NPT25901 Cell line Panel melanoma (Carcinoma cell lines) Homo sapiens TGI = -5.1 n.a. PMID[12036377]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 < 0.1 nM PMID[15857148]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 1.0 nM PMID[15857148]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 100.0 nM PMID[15857148]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 10.0 nM PMID[15857148]
NPT25901 Cell line Panel melanoma (Carcinoma cell lines) Homo sapiens GI50 = 158.49 nM PMID[17154522]
NPT25901 Cell line Panel melanoma (Carcinoma cell lines) Homo sapiens TGI = 7943.28 nM PMID[17154522]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 100.0 nM PMID[17559205]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 15848.93 nM PMID[17559205]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 3981.07 nM PMID[17559205]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 125.89 nM PMID[17559205]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 6309.57 nM PMID[17559205]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 158.49 nM PMID[17559205]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 7943.28 nM PMID[17559205]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 316.23 nM PMID[17559205]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 19952.62 nM PMID[17559205]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 100.0 nM PMID[19006285]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 125.89 nM PMID[19006285]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 316.23 nM PMID[19006285]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 3981.07 nM PMID[19006285]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 6309.57 nM PMID[19006285]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 19952.62 nM PMID[19006285]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 7943.28 nM PMID[19006285]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI = 0.1 uM PMID[19006285]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI = 0.13 uM PMID[19006285]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI = 0.32 uM PMID[19006285]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 100.0 nM PMID[18598018]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 15848.93 nM PMID[18598018]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 251.19 nM PMID[18598018]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 3981.07 nM PMID[18598018]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 125.89 nM PMID[18598018]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 6309.57 nM PMID[18598018]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 158.49 nM PMID[18598018]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 7943.28 nM PMID[18598018]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 316.23 nM PMID[18598018]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 19952.62 nM PMID[18598018]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 100.0 nM PMID[20395150]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 200.0 nM PMID[20395150]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 300.0 nM PMID[20395150]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 15800.0 nM PMID[20395150]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 4000.0 nM PMID[20395150]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 6300.0 nM PMID[20395150]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 7900.0 nM PMID[20395150]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 19900.0 nM PMID[20395150]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 100.0 nM PMID[20684599]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 15850.0 nM PMID[20684599]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 3980.0 nM PMID[20684599]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 130.0 nM PMID[20684599]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 6310.0 nM PMID[20684599]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 160.0 nM PMID[20684599]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 7940.0 nM PMID[20684599]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 320.0 nM PMID[20684599]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 19950.0 nM PMID[20684599]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 320.0 nM PMID[22283430]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 130.0 nM PMID[22283430]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 160.0 nM PMID[22283430]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 100.0 nM PMID[22283430]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 15850.0 nM PMID[22283430]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 3980.0 nM PMID[22283430]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 6310.0 nM PMID[22283430]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 7940.0 nM PMID[22283430]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 19950.0 nM PMID[22283430]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 51.0 % PMID[430477]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 0.0 % PMID[430477]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 76.0 % PMID[430477]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 1.5 day PMID[430477]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 15.0 % PMID[430477]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 100.0 nM PMID[24747749]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 15850.0 nM PMID[24747749]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 250.0 nM PMID[24747749]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 3980.0 nM PMID[24747749]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 160.0 nM PMID[24747749]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 7940.0 nM PMID[24747749]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 320.0 nM PMID[24747749]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 19950.0 nM PMID[24747749]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 130.0 nM PMID[24747749]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 6310.0 nM PMID[24747749]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 75.0 % PMID[412968]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. TGI = 77.0 % PMID[412968]
NPT20 Organism Candida albicans Candida albicans Inhibition = -0.39 % DOI[10.6019/CHEMBL4296181]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae Inhibition = 1.69 % DOI[10.6019/CHEMBL4296181]
NPT19 Organism Escherichia coli Escherichia coli Inhibition = 2.79 % DOI[10.6019/CHEMBL4296181]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa Inhibition = 1.62 % DOI[10.6019/CHEMBL4296181]
NPT85 Organism Filobasidiella neoformans Cryptococcus neoformans Inhibition = -1.83 % DOI[10.6019/CHEMBL4296181]
NPT2922 Organism Staphylococcus aureus subsp. aureus Staphylococcus aureus subsp. aureus Inhibition = -14.43 % DOI[10.6019/CHEMBL4296181]
NPT25900 Cell line Panel CNS (Carcinoma cell lines) Homo sapiens GI50 = 125.89 nM PMID[12036377]
NPT25903 Cell line Panel renal (Carcinoma cell lines) Homo sapiens GI50 = 316.23 nM PMID[12036377]
NPT25905 Cell line Panel breast (Carcinoma cell lines) Homo sapiens GI50 = 316.23 nM PMID[12036377]
NPT25900 Cell line Panel CNS (Carcinoma cell lines) Homo sapiens TGI = -5.2 n.a. PMID[12036377]
NPT25903 Cell line Panel renal (Carcinoma cell lines) Homo sapiens TGI = -4.7 n.a. PMID[12036377]
NPT25905 Cell line Panel breast (Carcinoma cell lines) Homo sapiens TGI = -5.1 n.a. PMID[12036377]
NPT2 Others Unspecified n.a. TGI = -5.0 n.a. PMID[12036377]
NPT25900 Cell line Panel CNS (Carcinoma cell lines) Homo sapiens GI50 = 125.89 nM PMID[17154522]
NPT25900 Cell line Panel CNS (Carcinoma cell lines) Homo sapiens TGI = 6309.57 nM PMID[17154522]
NPT25903 Cell line Panel renal (Carcinoma cell lines) Homo sapiens GI50 = 316.23 nM PMID[17154522]
NPT25903 Cell line Panel renal (Carcinoma cell lines) Homo sapiens TGI = 19952.62 nM PMID[17154522]
NPT25905 Cell line Panel breast (Carcinoma cell lines) Homo sapiens GI50 = 316.23 nM PMID[17154522]
NPT25905 Cell line Panel breast (Carcinoma cell lines) Homo sapiens TGI = 7943.28 nM PMID[17154522]
NPT27 Others Unspecified n.a. IC50 = 26.7 ug.mL-1 PMID[17432904]
NPT27 Others Unspecified n.a. IC50 = 28.4 ug.mL-1 PMID[17432904]
NPT27 Others Unspecified n.a. IC50 = 31.0 nM PMID[23215348]
NPT747 Organism Acinetobacter baumannii Acinetobacter baumannii Inhibition = -6.71 % DOI[10.6019/CHEMBL4296181]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference
- Rattus norvegicus LOEL = 0.03 mg/L ToxVal
- Rattus norvegicus LOEL = 0.01 mg/L ToxVal
- Rattus norvegicus LD50 = 1.0 mg.kg-1 PMID[412968]
- Mus musculus LD50 = 2.1 mg.kg-1 PMID[412968]
- Mus musculus LD50 = 2.1 mg.kg-1 PMID[430477]

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC489610 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9677 High Similarity NPC260909
0.7183 Intermediate Similarity NPC485509
0.6901 Remote Similarity NPC195788
0.6901 Remote Similarity NPC237901
0.5789 Remote Similarity NPC608514
0.5724 Remote Similarity NPC277353
0.5724 Remote Similarity NPC600057

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC489610 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
1.0 High Similarity NPD8459 Approved
0.9677 High Similarity NPD8460 Phase 4
0.7183 Intermediate Similarity NPD8465 Approved
0.6901 Remote Similarity NPD8466 Phase 4
0.6901 Remote Similarity NPD8467 Approved
0.6419 Remote Similarity NPD8363 Approved
0.6216 Remote Similarity NPD8364 Approved
0.6107 Remote Similarity NPD8489 Phase 1
0.6093 Remote Similarity NPD8365 Clinical (unspecified phase)
0.503 Remote Similarity NPD8427 Approved

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data